DeviceClearance

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)— 510(k) K150874

Substantially Equivalent

Novo Nordisk, Inc.

FDA 510(k) clearance K150874 for NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector), Substantially Equivalent on 2015-07-31. Applicant: Novo Nordisk, Inc.. Device class: 2.

Clearance details

Applicant
Novo Nordisk, Inc.
Product code
Code FMF
Device class
Class 2
Regulation
21 CFR 880.5860
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Plainsboro, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code FMF

view all

More clearances from Novo Nordisk, Inc.

view all

Adverse events under product code FMF

product code FMF
Death
15
Injury
2,263
Malfunction
29,722
Other
17
Total
32,017

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K150874

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K150874.

Data sourced from openFDA. This site is unofficial and independent of the FDA.